| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/23/2006 | WO2006031155A2 Identification of explosives by frequency domain microwave spectroscopy in reflection mode |
| 03/23/2006 | WO2006031117A1 Lipoxygenase inhibitor peptides and their use |
| 03/23/2006 | WO2006031105A1 Titre plate and measuring device for chemical and/or biochemical analysis |
| 03/23/2006 | WO2006030985A1 Method of assaying lipid peroxide |
| 03/23/2006 | WO2006030970A1 Nonhuman animal with ficolin-a gene function deleted |
| 03/23/2006 | WO2006030956A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF |
| 03/23/2006 | WO2006030866A1 Method of quantitative determination of uric acid |
| 03/23/2006 | WO2006030822A1 Gene expression data processing method and processing program |
| 03/23/2006 | WO2006030792A1 Pathologic model animal for non-alcoholic fatty hepatitis |
| 03/23/2006 | WO2006030784A1 SAMPLING METHOD AND SAMPLING DEVICE, AND logD MEASURING METHOD AND logD MEASURING SYSTEM |
| 03/23/2006 | WO2006030761A1 Novel diabetes-associated factor |
| 03/23/2006 | WO2006030749A1 Component-collecting device |
| 03/23/2006 | WO2006030693A1 Agents for overcoming hair troubles and method of screening the same |
| 03/23/2006 | WO2006030420A2 Continuous monitoring system |
| 03/23/2006 | WO2006030219A2 Assay method |
| 03/23/2006 | WO2006030218A1 Process for evaluating a refinery feedstock |
| 03/23/2006 | WO2006030215A1 Process for evaluating a refinery feedstock |
| 03/23/2006 | WO2006030126A2 Method of accelerating somatic mutations and use thereof in proteomics |
| 03/23/2006 | WO2006030023A1 Phosphorylated vimentin serving as a marker of the aggressiveness and/or invasiveness of tumors |
| 03/23/2006 | WO2006029836A2 Breast cancer proteins |
| 03/23/2006 | WO2006029735A1 Diagnostics and therapeutics for diseases associated with prostaglandin 12 receptor (ptgir) |
| 03/23/2006 | WO2006029727A1 Molecular imprinted material and inkjet recording element comprising said molecular imprinted material |
| 03/23/2006 | WO2006029719A2 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group h, member 4 (nr1h4) |
| 03/23/2006 | WO2006020755A9 Methods for identifying inhibitors of the mtor pathway as diabetes therapeutics |
| 03/23/2006 | WO2006020748A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 03/23/2006 | WO2006010634A8 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 03/23/2006 | WO2006010497A3 Diagnostics and therapeutics for diseases associated with choline kinase (chk) |
| 03/23/2006 | WO2006010494A3 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 1 (metapi) |
| 03/23/2006 | WO2006009733A3 Frozen tissue microarray |
| 03/23/2006 | WO2006000823A3 Composition and electrochemical sensor for detecting ischaemia |
| 03/23/2006 | WO2005124650A3 Sufficient and necessary reagent sets for chemogenomic analysis |
| 03/23/2006 | WO2005121805A3 Use of ferrofluids for phenotyping blood and related applications |
| 03/23/2006 | WO2005116643A3 Identification of compounds modifying a cellular response |
| 03/23/2006 | WO2005116637A3 Apparatus and method for measuring the composition of a mixture |
| 03/23/2006 | WO2005114930A3 Method and apparatus for identifying proteins in mixtures |
| 03/23/2006 | WO2005114205A3 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group b, member 2 (nr1b2) |
| 03/23/2006 | WO2005114184A3 Biological soil detector and method of using same |
| 03/23/2006 | WO2005113835A3 Kits and methods for indentification, assessment, prevention and therapy of breast cancer |
| 03/23/2006 | WO2005113788A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6) |
| 03/23/2006 | WO2005113720A3 A strategy for designing patient-specific anti-cancer drugs |
| 03/23/2006 | WO2005108999A3 Diagnostic and therapeutic use of kcnj6 for alzheimer’s disease |
| 03/23/2006 | WO2005103711A3 Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1) |
| 03/23/2006 | WO2005102938A3 Antibodies specific for bcr-abl fusion protein and uses thereof |
| 03/23/2006 | WO2005099774A3 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 03/23/2006 | WO2005098051A3 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 03/23/2006 | WO2005095987A3 Salivary soluble cd44: a molecular marker for head and neck cancer |
| 03/23/2006 | WO2005095975A3 Anti-fungal target genes |
| 03/23/2006 | WO2005095630A3 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 10 (map3k10) |
| 03/23/2006 | WO2005093426A3 Diagnostics and therapeutics for diseases associated with retinoic acid receptor alpha (rara) |
| 03/23/2006 | WO2005080983A3 Using liquid crystals to detect affinity microcontact printed biomolecules |
| 03/23/2006 | WO2005074553A3 Tablet holder device and methods for immersion testing |
| 03/23/2006 | WO2005073731A3 Cjd prion testing |
| 03/23/2006 | WO2005072470A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 03/23/2006 | WO2005071095A3 Fluorogenic kinase assays and substrates for kinases and phosphatases |
| 03/23/2006 | WO2005062706A3 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 03/23/2006 | WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles |
| 03/23/2006 | WO2005052131A3 C140rf35 as modifier of the beta catenin pathway and methods of use |
| 03/23/2006 | WO2005050201A3 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin |
| 03/23/2006 | WO2005050169A3 Sample collection cup with integrated activatable sample analysis system |
| 03/23/2006 | WO2005049794A3 Methods of characterizing infectious bursal disease virus |
| 03/23/2006 | WO2005048913A3 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 03/23/2006 | WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 03/23/2006 | WO2005046585A3 Vps35-based assays and methods for treating alzheimer’s disease |
| 03/23/2006 | WO2005041903A3 Methods and reagents for diagnosis and treatment of diabetes |
| 03/23/2006 | WO2005040191A3 Ccn1 compositions and methods |
| 03/23/2006 | WO2005037209A3 A method for the separation anti-amyloid beta antibody with amyloid beta peptide |
| 03/23/2006 | WO2005018431A3 Compositions and methods for detecting and treating neurological conditions |
| 03/23/2006 | WO2005017804A3 Methods and system for multi-drug treatment discovery |
| 03/23/2006 | WO2004111087A3 Chemokin-binding protein thap1, methods and use thereof |
| 03/23/2006 | WO2004104214A3 Methods and devices for multiplexing amplification reactions |
| 03/23/2006 | WO2004081537A3 Methods of evaluating caloric restriction and identifying caloric restriction mimetics |
| 03/23/2006 | WO2004076944A3 Gas monitoring system and sidestream gas measurement system adapted to communicate with a mainstream gas measurement system |
| 03/23/2006 | WO2004061088A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/23/2006 | WO2004016642A3 ISOFORM SPECIFIC INTERACTIONS OF APOLIPOPROTEIN E TO AN INTERMEDIATE CONFORMATION OF ALZHEIMER Aβ PEPTIDE |
| 03/23/2006 | WO2004006753A3 Sga-72m, a cancer associated antigen, and uses thereof |
| 03/23/2006 | WO2003087299A3 Methods of characterizing molecular interaction sites on proteins |
| 03/23/2006 | WO2003082202A3 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 03/23/2006 | WO2003076896A3 Use of biomarkers to detect breast cancer |
| 03/23/2006 | WO2003075855A3 Antibodies against cancer antigen tmeff2 and uses thereof |
| 03/23/2006 | WO2003049602A3 Diagnostic methods for protein profiling |
| 03/23/2006 | US20060064767 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 03/23/2006 | US20060064765 Obesity gene |
| 03/23/2006 | US20060064764 Increasing gamete production with a gene switch |
| 03/23/2006 | US20060064396 Liver disease diagnosis system, method and graphical user interface |
| 03/23/2006 | US20060064270 Analyzer and computer program product |
| 03/23/2006 | US20060064253 Multiple high-resolution serum proteomic features for ovarian cancer detection |
| 03/23/2006 | US20060064252 Small molecule mimetics of erythropoietin |
| 03/23/2006 | US20060064251 System for extracting compound differently interacting with bioactive polymer of interest |
| 03/23/2006 | US20060063983 Non-invasive blood component value measuring instrument and method |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063883 Indicator devices and articles comprising the indicator device |
| 03/23/2006 | US20060063727 Tr4/tr2 response elements |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060063711 Use of sglt homolog |
| 03/23/2006 | US20060063710 Flj20647s as modifiers of the p21 pathway and methods of use |
| 03/23/2006 | US20060063709 Nuclear factors associated with transcriptional regulation |
| 03/23/2006 | US20060063299 Scaffold-organized clusters and electronic devices made using such clusters |
| 03/23/2006 | US20060063276 Determining mobility of cells; enables novel assays for cell motility and/or spreading and screening tests for determining drugs and/or treatments effective in increasing or decreasing cell shape changes and/or motility on surfaces |
| 03/23/2006 | US20060063275 Predicting whether a pregnancy will proceed to term or will result in a spontaneous abortion or an ectopic pregnancy; measuring blood levels of hCG-hg and progesterone in a pregnant woman, determining a rate of change of progesterone levels from the blood measurements |
| 03/23/2006 | US20060063269 Fluorescent isotope tags and their method of use |